Health
In vitro testing suggests effective novel drug combinations for SARS-CoV-2 – News-Medical.Net
A recent study published on the preprint server bioRxiv* in September 2020 shows the value of drug combinations to enhance the therapeutic and preventive efficacy of such repositioned drugs in standard antiviral therapy.
Every year, emerging and re-emerging viruses, such as SARS-CoV-2, MERS-CoV, Zika virus, Ebola virus, influenza A virus, and Rift Valley fever virus surface from natural reservoirs to infect, disable, and kill people. Today, the number of people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to rise, with 30.9 million recorded infections and a global death toll nearing 1 million.
The high expense and delay associated with drug development is a significant de…
-
Noosa News23 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News22 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Business8 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General17 hours ago‘Potential’ hacker contacts Qantas over data breach